Author:
Xu Yingjie,Luo Lingfeng,Su Gaixiu,Zhu Jia,Kang Min,Zhang Dan,Lai Jianming,Li Xiaohui
Abstract
Abstract
Backgroud
To summarize the clinical characteristics and identify the risk factors for pediatric Takayasu arteritis (TAK) with coronary artery lesions (CALs).
Methods
Clinical data of pediatric TAK patients in our center were retrospectively assessed. Independent risk factors for CALs were identified using multivariate logistic regression analysis. Survival analysis was used to compare differences in survival rates between the groups.
Results
Among the 66 pediatric TAK cases, the incidence of accompanying CALs was 39.4%. In the CAL group, 19 (73.1%) cases started within 36 months. None of the patients had symptoms of angina or ischemia on electrocardiogram (ECG), the CALs were detected using coronary ultrasound. The CALs most commonly were the left main and right coronary arteries. The lesions were mostly small or middle coronary artery aneurysms; some children may have giant coronary aneurysmal dilations, thrombosis and heart failure. The age of onset and symptom onset to diagnosis in TAK patients with CAL were lower than those in TAK patients without CAL(P < 0.005). TAK patients with CAL had significantly higher CRP,WBC, PLT,TNF-α and IL-2R levels (P < 0.05), lower HGB (P = 0.01), lower rate of renal artery stenosis (RAS) (P = 0.009). In multivariate logistic regression, the risk factors for pediatric TAK combined with CAL included the age of TAK onset (OR = 0.9835, 95% CI: 0.9710–0.9946, P = 0.006) and RAS (OR = 0.1901, 95% CI: 0.0386–0.7503, P = 0.03). In addition, there was no significant difference in survival rates between the two groups after regular treatment.
Conclusion
This study showed that the occurrence of CAL in pediatric TAK patients has a relatively more rapid clinical course, and a stronger inflammatory state at the time of diagnosis. The earlier the age of TAK onset and without RAS are more likely to cause CAL.
Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Subject
Immunology and Allergy,Rheumatology,Pediatrics, Perinatology and Child Health
Reference42 articles.
1. Mehrdad Maz SA, Chung A, Abril, et al. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the management of Giant Cell Arteritis and Takayasu Arteritis. [J] Arthritis Rheumatol. 2021;73(8):1349–65.
2. XiaoLiang C, Dai ShengMing, Feng X et al. Takayasu’s arteritis: clinical features and outcomes of 125 patients in China. [J] Clin Rheumatol 2010,29(9):973–81.
3. Soto ME, Espinola N, Flores-Suarez LF et al. Takayasu arteritis: clinical features in 110 Mexican Mestizo patients and cardiovascular impact on survival and prognosis. [J] Clin Exp Rheumatol 2008,26(3 Suppl 49):S9–15.
4. Yuan S-M, Lin H-Z et al. Coronary artery involvements in Takayasu arteritis: systematic review of reports. [J] Gen Thorac Cardiovasc Surg 2020,68(9):883–904.
5. Fatos Onen N, Akkoc, et al. Epidemiology of Takayasu arteritis. [J] Presse Med. 2017;46(7–8 Pt 2):e197–e203.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献